Stephen A. Sherwin
Director at Neurocrine Biosciences · 12 reported transactions in 2 companies · latest trade Jun 5, 2026
Their trades
Sold | Jun 5, 2026 | Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days. | ||
Sold | Jun 5, 2026 | Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days. | ||
Sold | Jun 5, 2026 | Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days. | ||
Sold | Jun 5, 2026 | Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days. | ||
Sold | Jun 5, 2026 | Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days. |
$308.4K
Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days.
$970.9K
Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days.
$1.14M
Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days.
$419.2K
Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days.
$1.29M
Jun 5, 2026 close $163.88 → Oct 30, 2026 close $146.10. S&P 500 +2.5% over the same days.